輝大(上海)生物科技有限公司
姚璇博士為輝大基因創(chuàng)始人&首席執(zhí)行官,負(fù)責(zé)公司戰(zhàn)略布局、團(tuán)隊(duì)組建、項(xiàng)目推進(jìn)與體系建設(shè)。本科畢業(yè)于哈爾濱工業(yè)大學(xué),并在中科院神經(jīng)科學(xué)研究所獲得神經(jīng)生物學(xué)博士學(xué)位,創(chuàng)立輝大前曾擔(dān)任中科院神經(jīng)科學(xué)研究所副高級研究員。期間專注于新型基因編輯技術(shù)、動物模型建立及疾病治療應(yīng)用等多個(gè)領(lǐng)域的研究開發(fā),在國際高水平期刊發(fā)表多項(xiàng)成果并申請多項(xiàng)發(fā)明專利。
With a doctoral degree of Institute of Neuroscience, Chinese Academy of Sciences, Dr. Xuan Yao once served as Associate Senior Researcher at Institute of Neuroscience, Chinese Academy of Sciences, and has published many of his research achievements on Developmental Cell, Cell Research, Genome Biology and other international high-ranking journals.
Before founding HuidaGene, Dr. Yao efficiently constructed knock-in mouse models as well as the world’s first knock-in macaques by optimizing gene editing techniques, innovated CRISPR technology to specifically remove entire chromosomes, opening new avenues for modeling and generating therapies for diseases such as Down Syndrome, and worked out an efficient method for somatic cell knockins and technical solutions for the treatment of monogenic diseases. He has an international frontier vision and gains insights into business transformation in terms of the application of new gene editing techniques in animal modeling and in disease treatment.